ConductScience.org, home

Paper3865632

Cefotiam therapy of lower respiratory tract infections.

Polis MA and 1 other. Antimicrob Agents Chemother, 1985. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cefotiam therapy of lower respiratory tract infections. Papers, record 3865632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3865632

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cefotiam therapy of lower respiratory tract infections.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.07
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Polis MAM A
2Tuazon CUC U

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CefotaximeMajor topic
Respiratory Tract InfectionsMajor topic
Adult
Aged
Cefotiam
Female
Humans
Male
Middle Aged

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,325,707Antibiotic susceptibility testing by a standardized single disk method.Am J Clin Pathol1966https://conductscience.org/library/papers/5325707PubMed
24,893,892Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia.J Infect Dis1969https://conductscience.org/library/papers/4893892PubMed
31,127,999Microscopic and baceriologic analysis of expectorated sputum.Mayo Clin Proc1975https://conductscience.org/library/papers/1127999PubMed
4718,154SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/718154PubMed
56,331,302Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6331302PubMed
6371,539SCE-963, a new potent cephalosporin with high affinity for penicillin-binding proteins 1 and 3 of Escherichia coli.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/371539PubMed
7395,155Comparison of cefotiam and cefazolin activity against Gram-negative bacilli.J Antimicrob Chemother1979https://conductscience.org/library/papers/395155PubMed
86,294,043In-vitro activity of cefotiam against bacteria of clinical interest.J Antimicrob Chemother1982https://conductscience.org/library/papers/6294043PubMed
9738,967Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.J Antibiot (Tokyo)1978https://conductscience.org/library/papers/738967PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
24,764,9241-[2-(Di-methyl-aza-nium-yl)eth-yl]-1H-1,2,3,4-tetra-zole-5-thiol-ate.Acta Crystallogr Sect E Struct Rep Online2014https://conductscience.org/library/papers/24764924

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3865632

GET https://conductscience.org/api/papers/v1/3865632/authors